Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 20:00
Korro Bio Total Liabilities (Quarterly): 51.51M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 51.51M |
| March 31, 2024 | 46.63M |
| September 30, 2023 | 249.09M |
| Date | Value |
|---|---|
| June 30, 2023 | 244.74M |
| December 31, 2022 | 172.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
46.63M
Minimum
Mar 2024
249.09M
Maximum
Sep 2023
152.95M
Average
172.77M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics Inc | 1.972M |
| Pliant Therapeutics Inc | 99.84M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.59M |
| Shareholders Equity (Quarterly) | 198.08M |